Redcare Pharmacy N.V.
SAEYYOTCHealthcare● Active
$5.50
+$0.00(+0.00%)
Market Cap$1.1B
P/E Ratio—
52W High$12.6
52W Low$3.59
Redcare Pharmacy N.V. (SAEYY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SAEYY · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2025Report Date: Dec 31, 2025EPS Actual
-$0.17
Revenue
$0.93B
Fiscal Period
Q4 FY2025
FY ends December
Report Date
Dec 31, 2025
After Market Close
SAEYY reports quarterly as a OTC-listed Medical - Pharmaceuticals company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q4 FY2025 | Dec 31, 2025 | — | -$0.17 | — | $0.93B | — | — |
| — Q4 FY2025 | Oct 29, 2025 | — | -$0.04 | — | $0.84B | — | — |
| — Q3 FY2025 | Jul 29, 2025 | — | $0.05 | — | $0.84B | $0.72B | +16.3% |
| — Q2 FY2025 | May 6, 2025 | — | -$0.59 | — | $0.79B | $0.71B | +10.9% |
| — Q4 FY2024 | Dec 31, 2024 | — | -$1.35 | — | $0.70B | — | — |
| — Q4 FY2024 | Nov 5, 2024 | — | -$0.39 | — | $0.64B | $0.69B | -6.9% |
| — Q3 FY2024 | Jul 30, 2024 | — | -$0.23 | — | $0.60B | — | — |
| — Q2 FY2024 | Apr 25, 2024 | — | -$0.42 | — | $0.60B | — | — |
Q4 FY2025
Dec 31, 2025
EPS Actual
-$0.17
EPS Est.
—
EPS Surpr.
—
Revenue
$0.93B
Q4 FY2025
Oct 29, 2025
EPS Actual
-$0.04
EPS Est.
—
EPS Surpr.
—
Revenue
$0.84B
Q3 FY2025
Jul 29, 2025
EPS Actual
$0.05
EPS Est.
—
EPS Surpr.
—
Revenue
$0.84B
Q2 FY2025
May 6, 2025
EPS Actual
-$0.59
EPS Est.
—
EPS Surpr.
—
Revenue
$0.79B
Q4 FY2024
Dec 31, 2024
EPS Actual
-$1.35
EPS Est.
—
EPS Surpr.
—
Revenue
$0.70B
Q4 FY2024
Nov 5, 2024
EPS Actual
-$0.39
EPS Est.
—
EPS Surpr.
—
Revenue
$0.64B
Q3 FY2024
Jul 30, 2024
EPS Actual
-$0.23
EPS Est.
—
EPS Surpr.
—
Revenue
$0.60B
Q2 FY2024
Apr 25, 2024
EPS Actual
-$0.42
EPS Est.
—
EPS Surpr.
—
Revenue
$0.60B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2024 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.7B | $0.7B | $0.7B | 1 |
| Q3 FY2025 | $0.6B | $0.6B | $0.6B | 3 |
| Q2 FY2025 | $0.6B | $0.6B | $0.6B | 1 |
| Q1 FY2025 | $0.6B | $0.7B | $0.7B | 2 |
| Q4 FY2024 | $0.6B | $0.6B | $0.6B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2025 | Dec 31, 2025 | — | $7.50 | $7.50 | +0.00% |
| — Q4 FY2025 | Oct 29, 2025 | — | $9.18 | $9.18 | +0.00% |
| — Q3 FY2025 | Jul 29, 2025 | — | $12.60 | $12.60 | +0.00% |
| — Q2 FY2025 | May 6, 2025 | — | $14.80 | $14.80 | +0.00% |
| — Q4 FY2024 | Dec 31, 2024 | — | $13.88 | $13.88 | +0.00% |
| — Q4 FY2024 | Nov 5, 2024 | — | $15.58 | $15.58 | +0.00% |
| — Q3 FY2024 | Jul 30, 2024 | — | $15.40 | $15.65 | +1.62% |
| — Q2 FY2024 | Apr 25, 2024 | — | No price data | $15.08 | — |
Q4 FY2025+0.00%
Report Date
Dec 31, 2025
EPS Beat/Miss
—
Price Before
$7.50
Price After
$7.50
Q4 FY2025+0.00%
Report Date
Oct 29, 2025
EPS Beat/Miss
—
Price Before
$9.18
Price After
$9.18
Q3 FY2025+0.00%
Report Date
Jul 29, 2025
EPS Beat/Miss
—
Price Before
$12.60
Price After
$12.60
Q2 FY2025+0.00%
Report Date
May 6, 2025
EPS Beat/Miss
—
Price Before
$14.80
Price After
$14.80
Q4 FY2024+0.00%
Report Date
Dec 31, 2024
EPS Beat/Miss
—
Price Before
$13.88
Price After
$13.88
Q4 FY2024+0.00%
Report Date
Nov 5, 2024
EPS Beat/Miss
—
Price Before
$15.58
Price After
$15.58
Q3 FY2024+1.62%
Report Date
Jul 30, 2024
EPS Beat/Miss
—
Price Before
$15.40
Price After
$15.65
Q2 FY2024—
Report Date
Apr 25, 2024
EPS Beat/Miss
—
Price Before
—
Price After
$15.08
Beat Rate0 / 8 quarters
Largest Move+1.62% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SAEYY ends December
Redcare Pharmacy N.V. (SAEYY) most recently reported earnings on December 31, 2025 for Q4 FY2025, posting EPS of $-0.17 (in line with the analyst consensus of —). The next SAEYY earnings date is expected around September 1, 2026.
Each quarter, investors track SAEYY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SAEYY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SAEYY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SAEYY earnings · 4 questionsRedcare Pharmacy N.V.'s next earnings report is expected around September 1, 2026. SAEYY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SAEYY historically reports after market close (AMC).
SAEYY earnings datewhen is SAEYY earningsSAEYY next earnings datewhen does SAEYY report earningsSAEYY earnings calendar
▸ Source: FMP · Redcare Pharmacy N.V. SEC filings · US GAAP · Redcare Pharmacy N.V. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026